Gene Ontology terms associated with a binding site
- Binding site
- Motif_431
- Name
- E2Fb
- Description
- Arabidopsis E2F1 binds a sequence present in the promoter of S-phase-regulated gene AtCDC6 and is a member of a multigene family with differential activities
- #Associated genes
- 46
- #Associated GO terms
- 369
Biological Process
Molecular Function
Cellular Component
Cellular Component (back to top)
Click table-header(s) to enable sortingGO | Description | #Associated genes | ath | bra | cme | egr | gma | ptr | ppe | sly | stu | vvi |
---|---|---|---|---|---|---|---|---|---|---|---|---|
GO:0005623 | cell | 30 (65.22%) | 4 | 1 | 2 | 1 | 6 | 5 | 1 | 4 | 3 | 3 |
GO:0044464 | cell part | 30 (65.22%) | 4 | 1 | 2 | 1 | 6 | 5 | 1 | 4 | 3 | 3 |
GO:0005622 | intracellular | 23 (50.00%) | 4 | 1 | 1 | 1 | 5 | 4 | 1 | 2 | 2 | 2 |
GO:0044424 | intracellular part | 23 (50.00%) | 4 | 1 | 1 | 1 | 5 | 4 | 1 | 2 | 2 | 2 |
GO:0043229 | intracellular organelle | 22 (47.83%) | 3 | 1 | 1 | 1 | 5 | 4 | 1 | 2 | 2 | 2 |
GO:0043226 | organelle | 22 (47.83%) | 3 | 1 | 1 | 1 | 5 | 4 | 1 | 2 | 2 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 21 (45.65%) | 3 | 1 | 1 | 1 | 4 | 4 | 1 | 2 | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 21 (45.65%) | 3 | 1 | 1 | 1 | 4 | 4 | 1 | 2 | 2 | 2 |
GO:0005737 | cytoplasm | 16 (34.78%) | 2 | 1 | 0 | 1 | 4 | 3 | 1 | 1 | 1 | 2 |
GO:0044444 | cytoplasmic part | 15 (32.61%) | 1 | 1 | 0 | 1 | 4 | 3 | 1 | 1 | 1 | 2 |
GO:0005634 | nucleus | 11 (23.91%) | 2 | 0 | 1 | 0 | 2 | 2 | 1 | 1 | 1 | 1 |
GO:0071944 | cell periphery | 9 (19.57%) | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 2 | 1 | 2 |
GO:0009507 | chloroplast | 9 (19.57%) | 1 | 1 | 0 | 1 | 2 | 2 | 0 | 1 | 1 | 0 |
GO:0009536 | plastid | 9 (19.57%) | 1 | 1 | 0 | 1 | 2 | 2 | 0 | 1 | 1 | 0 |
GO:0016020 | membrane | 6 (13.04%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 1 | 1 |
GO:0005886 | plasma membrane | 6 (13.04%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 1 | 1 |
GO:0005694 | chromosome | 5 (10.87%) | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 |
GO:0005829 | cytosol | 5 (10.87%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 5 (10.87%) | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 |
GO:0043228 | non-membrane-bounded organelle | 5 (10.87%) | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 |
GO:0005618 | cell wall | 3 (6.52%) | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
GO:0030312 | external encapsulating structure | 3 (6.52%) | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
GO:0048046 | apoplast | 2 (4.35%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0030054 | cell junction | 2 (4.35%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0005911 | cell-cell junction | 2 (4.35%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0005576 | extracellular region | 2 (4.35%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0032991 | macromolecular complex | 2 (4.35%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0009506 | plasmodesma | 2 (4.35%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0055044 | symplast | 2 (4.35%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0044427 | chromosomal part | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0000775 | chromosome, centromeric region | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0044446 | intracellular organelle part | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0031090 | organelle membrane | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0044422 | organelle part | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0043234 | protein complex | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0032993 | protein-DNA complex | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0005774 | vacuolar membrane | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0044437 | vacuolar part | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0005773 | vacuole | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Biological Process (back to top)
Click table-header(s) to enable sortingGO | Description | #Associated genes | ath | bra | cme | egr | gma | ptr | ppe | sly | stu | vvi |
---|---|---|---|---|---|---|---|---|---|---|---|---|
GO:0009987 | cellular process | 23 (50.00%) | 2 | 0 | 4 | 0 | 7 | 1 | 1 | 3 | 3 | 2 |
GO:0008152 | metabolic process | 23 (50.00%) | 2 | 0 | 4 | 0 | 7 | 1 | 2 | 3 | 3 | 1 |
GO:0044237 | cellular metabolic process | 21 (45.65%) | 2 | 0 | 4 | 0 | 7 | 1 | 0 | 3 | 3 | 1 |
GO:0071704 | organic substance metabolic process | 21 (45.65%) | 2 | 0 | 4 | 0 | 7 | 1 | 0 | 3 | 3 | 1 |
GO:0044260 | cellular macromolecule metabolic process | 19 (41.30%) | 2 | 0 | 4 | 0 | 5 | 1 | 0 | 3 | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 19 (41.30%) | 2 | 0 | 4 | 0 | 5 | 1 | 0 | 3 | 3 | 1 |
GO:0044238 | primary metabolic process | 19 (41.30%) | 2 | 0 | 4 | 0 | 5 | 1 | 0 | 3 | 3 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 16 (34.78%) | 2 | 0 | 1 | 0 | 7 | 1 | 0 | 2 | 2 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 16 (34.78%) | 2 | 0 | 1 | 0 | 7 | 1 | 0 | 2 | 2 | 1 |
GO:0044699 | single-organism process | 16 (34.78%) | 2 | 0 | 2 | 0 | 4 | 1 | 3 | 1 | 1 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 14 (30.43%) | 2 | 0 | 1 | 0 | 5 | 1 | 0 | 2 | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 14 (30.43%) | 2 | 0 | 1 | 0 | 5 | 1 | 0 | 2 | 2 | 1 |
GO:0006807 | nitrogen compound metabolic process | 14 (30.43%) | 2 | 0 | 1 | 0 | 5 | 1 | 0 | 2 | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 14 (30.43%) | 2 | 0 | 1 | 0 | 5 | 1 | 0 | 2 | 2 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 14 (30.43%) | 2 | 0 | 1 | 0 | 5 | 1 | 0 | 2 | 2 | 1 |
GO:0044763 | single-organism cellular process | 13 (28.26%) | 1 | 0 | 2 | 0 | 4 | 1 | 1 | 1 | 1 | 2 |
GO:0065007 | biological regulation | 12 (26.09%) | 2 | 0 | 1 | 0 | 4 | 2 | 0 | 1 | 1 | 1 |
GO:0050789 | regulation of biological process | 12 (26.09%) | 2 | 0 | 1 | 0 | 4 | 2 | 0 | 1 | 1 | 1 |
GO:0050794 | regulation of cellular process | 11 (23.91%) | 2 | 0 | 1 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0032774 | RNA biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0016070 | RNA metabolic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0019438 | aromatic compound biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0009058 | biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0044249 | cellular biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0034645 | cellular macromolecule biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0010467 | gene expression | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0018130 | heterocycle biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0009059 | macromolecule biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:1901362 | organic cyclic compound biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:1901576 | organic substance biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:2001141 | regulation of RNA biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0051252 | regulation of RNA metabolic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0009889 | regulation of biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0031326 | regulation of cellular biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0031323 | regulation of cellular metabolic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0010468 | regulation of gene expression | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0010556 | regulation of macromolecule biosynthetic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0019222 | regulation of metabolic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0080090 | regulation of primary metabolic process | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0006355 | regulation of transcription, DNA-dependent | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0006351 | transcription, DNA-templated | 10 (21.74%) | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 1 | 1 | 1 |
GO:0044267 | cellular protein metabolic process | 9 (19.57%) | 0 | 0 | 3 | 0 | 2 | 1 | 0 | 1 | 1 | 1 |
GO:0006464 | cellular protein modification process | 9 (19.57%) | 0 | 0 | 3 | 0 | 2 | 1 | 0 | 1 | 1 | 1 |
GO:0043412 | macromolecule modification | 9 (19.57%) | 0 | 0 | 3 | 0 | 2 | 1 | 0 | 1 | 1 | 1 |
GO:0019538 | protein metabolic process | 9 (19.57%) | 0 | 0 | 3 | 0 | 2 | 1 | 0 | 1 | 1 | 1 |
GO:0036211 | protein modification process | 9 (19.57%) | 0 | 0 | 3 | 0 | 2 | 1 | 0 | 1 | 1 | 1 |
GO:0044710 | single-organism metabolic process | 9 (19.57%) | 0 | 0 | 1 | 0 | 4 | 1 | 2 | 0 | 0 | 1 |
GO:0016043 | cellular component organization | 8 (17.39%) | 0 | 0 | 2 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0071840 | cellular component organization or biogenesis | 8 (17.39%) | 0 | 0 | 2 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0006996 | organelle organization | 8 (17.39%) | 0 | 0 | 2 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0050896 | response to stimulus | 7 (15.22%) | 1 | 0 | 2 | 0 | 0 | 0 | 2 | 1 | 1 | 0 |
GO:0051276 | chromosome organization | 6 (13.04%) | 0 | 0 | 1 | 0 | 2 | 1 | 1 | 0 | 0 | 1 |
GO:0032502 | developmental process | 6 (13.04%) | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
GO:0007275 | multicellular organismal development | 6 (13.04%) | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
GO:0032501 | multicellular organismal process | 6 (13.04%) | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
GO:0006950 | response to stress | 6 (13.04%) | 1 | 0 | 1 | 0 | 0 | 0 | 2 | 1 | 1 | 0 |
GO:0044707 | single-multicellular organism process | 6 (13.04%) | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
GO:0044767 | single-organism developmental process | 6 (13.04%) | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
GO:0048856 | anatomical structure development | 5 (10.87%) | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
GO:0016568 | chromatin modification | 5 (10.87%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 1 |
GO:0006325 | chromatin organization | 5 (10.87%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 5 (10.87%) | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0006793 | phosphorus metabolic process | 5 (10.87%) | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0016310 | phosphorylation | 5 (10.87%) | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0006468 | protein phosphorylation | 5 (10.87%) | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0048731 | system development | 5 (10.87%) | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
GO:0071103 | DNA conformation change | 4 (8.70%) | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
GO:0006259 | DNA metabolic process | 4 (8.70%) | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
GO:0006265 | DNA topological change | 4 (8.70%) | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
GO:0048869 | cellular developmental process | 4 (8.70%) | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0006342 | chromatin silencing | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0006348 | chromatin silencing at telomere | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0016569 | covalent chromatin modification | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0016458 | gene silencing | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0016573 | histone acetylation | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0016570 | histone modification | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0018393 | internal peptidyl-lysine acetylation | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0006475 | internal protein amino acid acetylation | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0051253 | negative regulation of RNA metabolic process | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0048519 | negative regulation of biological process | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0009890 | negative regulation of biosynthetic process | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0031327 | negative regulation of cellular biosynthetic process | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0031324 | negative regulation of cellular metabolic process | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0048523 | negative regulation of cellular process | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0010629 | negative regulation of gene expression | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0045814 | negative regulation of gene expression, epigenetic | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0009892 | negative regulation of metabolic process | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0048513 | organ development | 4 (8.70%) | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0055114 | oxidation-reduction process | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 0 | 2 | 0 | 0 | 0 |
GO:0018193 | peptidyl-amino acid modification | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0018394 | peptidyl-lysine acetylation | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0018205 | peptidyl-lysine modification | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0006473 | protein acetylation | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0043543 | protein acylation | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0040029 | regulation of gene expression, epigenetic | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0042221 | response to chemical | 4 (8.70%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:1901700 | response to oxygen-containing compound | 4 (8.70%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0019439 | aromatic compound catabolic process | 3 (6.52%) | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0009056 | catabolic process | 3 (6.52%) | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0007049 | cell cycle | 3 (6.52%) | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0030154 | cell differentiation | 3 (6.52%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0045165 | cell fate commitment | 3 (6.52%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0001708 | cell fate specification | 3 (6.52%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0044248 | cellular catabolic process | 3 (6.52%) | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0051716 | cellular response to stimulus | 3 (6.52%) | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009913 | epidermal cell differentiation | 3 (6.52%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0009957 | epidermal cell fate specification | 3 (6.52%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0008544 | epidermis development | 3 (6.52%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0030855 | epithelial cell differentiation | 3 (6.52%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0060429 | epithelium development | 3 (6.52%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:1901361 | organic cyclic compound catabolic process | 3 (6.52%) | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:1901575 | organic substance catabolic process | 3 (6.52%) | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0000003 | reproduction | 3 (6.52%) | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0009628 | response to abiotic stimulus | 3 (6.52%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0009409 | response to cold | 3 (6.52%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0010035 | response to inorganic substance | 3 (6.52%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0006970 | response to osmotic stress | 3 (6.52%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0009266 | response to temperature stimulus | 3 (6.52%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0009415 | response to water | 3 (6.52%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0009414 | response to water deprivation | 3 (6.52%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0044712 | single-organism catabolic process | 3 (6.52%) | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0043588 | skin development | 3 (6.52%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0009888 | tissue development | 3 (6.52%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0007154 | cell communication | 2 (4.35%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0022402 | cell cycle process | 2 (4.35%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0048610 | cellular process involved in reproduction | 2 (4.35%) | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0070887 | cellular response to chemical stimulus | 2 (4.35%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0071495 | cellular response to endogenous stimulus | 2 (4.35%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0032870 | cellular response to hormone stimulus | 2 (4.35%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0071310 | cellular response to organic substance | 2 (4.35%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0003006 | developmental process involved in reproduction | 2 (4.35%) | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0048229 | gametophyte development | 2 (4.35%) | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0009755 | hormone-mediated signaling pathway | 2 (4.35%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0046274 | lignin catabolic process | 2 (4.35%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0009808 | lignin metabolic process | 2 (4.35%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0051321 | meiotic cell cycle | 2 (4.35%) | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0046271 | phenylpropanoid catabolic process | 2 (4.35%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0009698 | phenylpropanoid metabolic process | 2 (4.35%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0009791 | post-embryonic development | 2 (4.35%) | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0022414 | reproductive process | 2 (4.35%) | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0048608 | reproductive structure development | 2 (4.35%) | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0061458 | reproductive system development | 2 (4.35%) | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0009719 | response to endogenous stimulus | 2 (4.35%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009644 | response to high light intensity | 2 (4.35%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0009725 | response to hormone | 2 (4.35%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009642 | response to light intensity | 2 (4.35%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0009416 | response to light stimulus | 2 (4.35%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0010033 | response to organic substance | 2 (4.35%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006979 | response to oxidative stress | 2 (4.35%) | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
GO:0009314 | response to radiation | 2 (4.35%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0009651 | response to salt stress | 2 (4.35%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0019748 | secondary metabolic process | 2 (4.35%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0007165 | signal transduction | 2 (4.35%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0023052 | signaling | 2 (4.35%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0044700 | single organism signaling | 2 (4.35%) | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0043044 | ATP-dependent chromatin remodeling | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0006308 | DNA catabolic process | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0000738 | DNA catabolic process, exonucleolytic | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0000729 | DNA double-strand break processing | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006310 | DNA recombination | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006281 | DNA repair | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0007030 | Golgi organization | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009838 | abscission | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009742 | brassinosteroid mediated signaling pathway | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051301 | cell division | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0016049 | cell growth | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0022607 | cellular component assembly | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0044085 | cellular component biogenesis | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0044265 | cellular macromolecule catabolic process | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0044270 | cellular nitrogen compound catabolic process | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006974 | cellular response to DNA damage stimulus | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0097306 | cellular response to alcohol | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0071367 | cellular response to brassinosteroid stimulus | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0071369 | cellular response to ethylene stimulus | 1 (2.17%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0071396 | cellular response to lipid | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0071407 | cellular response to organic cyclic compound | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:1901701 | cellular response to oxygen-containing compound | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0071383 | cellular response to steroid hormone stimulus | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0033554 | cellular response to stress | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051026 | chiasma assembly | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006338 | chromatin remodeling | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0070192 | chromosome organization involved in meiosis | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0007059 | chromosome segregation | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0007623 | circadian rhythm | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0021700 | developmental maturation | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006302 | double-strand break repair | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009790 | embryo development | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009793 | embryo development ending in seed dormancy | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009553 | embryo sac development | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0009873 | ethylene mediated signaling pathway | 1 (2.17%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010227 | floral organ abscission | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048437 | floral organ development | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009908 | flower development | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010154 | fruit development | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0040007 | growth | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0046700 | heterocycle catabolic process | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009057 | macromolecule catabolic process | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0034090 | maintenance of meiotic sister chromatid cohesion | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0034086 | maintenance of sister chromatid cohesion | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0007126 | meiosis | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0007127 | meiosis I | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0042138 | meiotic DNA double-strand break formation | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0000706 | meiotic DNA double-strand break processing | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0045132 | meiotic chromosome segregation | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051177 | meiotic sister chromatid cohesion | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009556 | microsporogenesis | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0007067 | mitosis | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0000278 | mitotic cell cycle | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0000280 | nuclear division | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0034655 | nucleobase-containing compound catabolic process | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048285 | organelle fission | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0000160 | phosphorelay signal transduction system | 1 (2.17%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048236 | plant-type spore development | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009555 | pollen development | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010152 | pollen maturation | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048569 | post-embryonic organ development | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0046777 | protein autophosphorylation | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0035825 | reciprocal DNA recombination | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0007131 | reciprocal meiotic recombination | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0042752 | regulation of circadian rhythm | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0097305 | response to alcohol | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009741 | response to brassinosteroid | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009723 | response to ethylene | 1 (2.17%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0033993 | response to lipid | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0014070 | response to organic cyclic compound | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048545 | response to steroid hormone | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048511 | rhythmic process | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048316 | seed development | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048367 | shoot system development | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0044702 | single organism reproductive process | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0007062 | sister chromatid cohesion | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0043401 | steroid hormone mediated signaling pathway | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0007129 | synapsis | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010228 | vegetative to reproductive phase transition of meristem | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Molecular Function (back to top)
Click table-header(s) to enable sortingGO | Description | #Associated genes | ath | bra | cme | egr | gma | ptr | ppe | sly | stu | vvi |
---|---|---|---|---|---|---|---|---|---|---|---|---|
GO:0005488 | binding | 34 (73.91%) | 2 | 1 | 5 | 1 | 9 | 4 | 3 | 4 | 4 | 1 |
GO:0003824 | catalytic activity | 27 (58.70%) | 0 | 1 | 5 | 1 | 7 | 3 | 3 | 3 | 3 | 1 |
GO:1901363 | heterocyclic compound binding | 26 (56.52%) | 2 | 1 | 4 | 1 | 5 | 2 | 3 | 4 | 4 | 0 |
GO:0097159 | organic cyclic compound binding | 26 (56.52%) | 2 | 1 | 4 | 1 | 5 | 2 | 3 | 4 | 4 | 0 |
GO:0043167 | ion binding | 21 (45.65%) | 0 | 1 | 5 | 1 | 5 | 2 | 1 | 3 | 3 | 0 |
GO:0003677 | DNA binding | 19 (41.30%) | 2 | 1 | 1 | 1 | 5 | 2 | 1 | 3 | 3 | 0 |
GO:0003676 | nucleic acid binding | 19 (41.30%) | 2 | 1 | 1 | 1 | 5 | 2 | 1 | 3 | 3 | 0 |
GO:0016787 | hydrolase activity | 14 (30.43%) | 0 | 1 | 2 | 1 | 3 | 2 | 1 | 2 | 2 | 0 |
GO:0005515 | protein binding | 13 (28.26%) | 1 | 0 | 2 | 0 | 2 | 2 | 1 | 2 | 2 | 1 |
GO:0043169 | cation binding | 11 (23.91%) | 0 | 1 | 1 | 1 | 4 | 2 | 0 | 1 | 1 | 0 |
GO:0046872 | metal ion binding | 11 (23.91%) | 0 | 1 | 1 | 1 | 4 | 2 | 0 | 1 | 1 | 0 |
GO:0005524 | ATP binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:0030554 | adenyl nucleotide binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:0032559 | adenyl ribonucleotide binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:0043168 | anion binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:0097367 | carbohydrate derivative binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:0001882 | nucleoside binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:1901265 | nucleoside phosphate binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:0000166 | nucleotide binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:0001883 | purine nucleoside binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:0017076 | purine nucleotide binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:0032550 | purine ribonucleoside binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:0035639 | purine ribonucleoside triphosphate binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:0032555 | purine ribonucleotide binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:0032549 | ribonucleoside binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:0032553 | ribonucleotide binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:0036094 | small molecule binding | 10 (21.74%) | 0 | 0 | 4 | 0 | 1 | 0 | 1 | 2 | 2 | 0 |
GO:0016740 | transferase activity | 9 (19.57%) | 0 | 0 | 3 | 0 | 2 | 1 | 0 | 1 | 1 | 1 |
GO:0003723 | RNA binding | 8 (17.39%) | 0 | 1 | 0 | 1 | 2 | 2 | 0 | 1 | 1 | 0 |
GO:0016788 | hydrolase activity, acting on ester bonds | 8 (17.39%) | 0 | 1 | 0 | 1 | 2 | 2 | 0 | 1 | 1 | 0 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 5 (10.87%) | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 5 (10.87%) | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 |
GO:0016301 | kinase activity | 5 (10.87%) | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0017111 | nucleoside-triphosphatase activity | 5 (10.87%) | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 5 (10.87%) | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0004672 | protein kinase activity | 5 (10.87%) | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0016462 | pyrophosphatase activity | 5 (10.87%) | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 5 (10.87%) | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0016887 | ATPase activity | 4 (8.70%) | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
GO:0042623 | ATPase activity, coupled | 4 (8.70%) | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
GO:0061505 | DNA topoisomerase II activity | 4 (8.70%) | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
GO:0003916 | DNA topoisomerase activity | 4 (8.70%) | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity | 4 (8.70%) | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
GO:0008094 | DNA-dependent ATPase activity | 4 (8.70%) | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
GO:0010485 | H4 histone acetyltransferase activity | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0008080 | N-acetyltransferase activity | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0016410 | N-acyltransferase activity | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0016407 | acetyltransferase activity | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0004402 | histone acetyltransferase activity | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0042802 | identical protein binding | 4 (8.70%) | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
GO:0016853 | isomerase activity | 4 (8.70%) | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
GO:0016491 | oxidoreductase activity | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 0 | 2 | 0 | 0 | 0 |
GO:0004674 | protein serine/threonine kinase activity | 4 (8.70%) | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0016746 | transferase activity, transferring acyl groups | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0016747 | transferase activity, transferring acyl groups other than amino-acyl groups | 4 (8.70%) | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
GO:0001071 | nucleic acid binding transcription factor activity | 3 (6.52%) | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3 (6.52%) | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0046914 | transition metal ion binding | 3 (6.52%) | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0016209 | antioxidant activity | 2 (4.35%) | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
GO:0005507 | copper ion binding | 2 (4.35%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0020037 | heme binding | 2 (4.35%) | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
GO:0052716 | hydroquinone:oxygen oxidoreductase activity | 2 (4.35%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0060089 | molecular transducer activity | 2 (4.35%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors | 2 (4.35%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0016682 | oxidoreductase activity, acting on diphenols and related substances as donors, oxygen as acceptor | 2 (4.35%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor | 2 (4.35%) | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
GO:0004601 | peroxidase activity | 2 (4.35%) | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
GO:0004872 | receptor activity | 2 (4.35%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0004871 | signal transducer activity | 2 (4.35%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0038023 | signaling receptor activity | 2 (4.35%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0046906 | tetrapyrrole binding | 2 (4.35%) | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
GO:0019199 | transmembrane receptor protein kinase activity | 2 (4.35%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0004675 | transmembrane receptor protein serine/threonine kinase activity | 2 (4.35%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0004888 | transmembrane signaling receptor activity | 2 (4.35%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
GO:0003682 | chromatin binding | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0004386 | helicase activity | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0031491 | nucleosome binding | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0032403 | protein complex binding | 1 (2.17%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0004713 | protein tyrosine kinase activity | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0005102 | receptor binding | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0033612 | receptor serine/threonine kinase binding | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0043565 | sequence-specific DNA binding | 1 (2.17%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0008270 | zinc ion binding | 1 (2.17%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |